SphingoTec logo

SphingoTec

Improving patient outcomes with innovative diagnostics for acute care: Actionable insights in real-time

30 employees · est. 2002 · Hennigsdorf, Germany

VS
Viome Life Sciences logo

Viome Life Sciences

We're on a mission to decode human biology in order to prevent and reverse chronic diseases, cancers, and aging.

30 employees · est. 2016 · Bellevue, United States

SphingoTec is the older company (2002 vs 2016).

Side-by-Side Comparison

SphingoTec Viome Life Sciences
Founded
2002 older 2016
Headquarters
Hennigsdorf, Germany Bellevue, United States
Employees
30 30
Industry
Biotechnology Health Care
Funding Stage
Series B Series Unknown
Total Funding
$1.50M Not tracked yet
Funding Rounds
4 1
Services
biomarker development, out-licensing of diagnostic solutions, critical care diagnostics, IVD assay provision Not tracked yet
Target Customers
research laboratories, pharmaceutical companies, critical care units, clinicians, transplant centers Not tracked yet
Taxonomy
Innovative Diagnostics, Acute Care, Biomarkers, Acute Heart Failure, Acute Kidney Injury, Circulatory Shock, Patient Management, Treatment Strategies, Health Risk Prediction, Obesity Biomarkers, Cardiovascular Disease Biomarkers, Breast Cancer Biomarkers, Sepsis Diagnostics, In Vitro Diagnostics, Blood-based Protein Biomarkers Genomics, Microbiome Analysis, Precision Medicine, AI In Healthcare, Chronic Disease Prevention, Cancer Diagnostics, Aging Research, Molecular Biology, Precision Therapeutics, Predictive Medicine
Website
sphingotec.com viomelifesciences.com
SphingoTec logo

About SphingoTec

Founded in 2002, SphingoTec GmbH is a pioneering player in the Biotechnology sector, based in Germany. The company focuses on developing innovative biomarkers to diagnose, predict, and monitor acute medical conditions such as heart failure, kidney injury, and circulatory shock, with the aim of enhan...

Viome Life Sciences logo

About Viome Life Sciences

Viome Life Sciences, founded in 2016, is dedicated to decoding human biology to prevent and reverse chronic diseases, cancers, and aging. The company's Consumer Services (VIOME) offers a direct-to-consumer healthcare test analyzing microbial and human gene expressions utilizing proprietary technolog...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at SphingoTec and Viome Life Sciences — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at SphingoTec and Viome Life Sciences — by email.

Frequently Asked Questions

SphingoTec — Improving patient outcomes with innovative diagnostics for acute care: Actionable insights in real-time . Viome Life Sciences — We're on a mission to decode human biology in order to prevent and reverse chronic diseases, cancers, and aging. . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
SphingoTec has raised $1.50M while Viome Life Sciences has raised undisclosed funding.
SphingoTec and Viome Life Sciences operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare SphingoTec with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy